AstraZeneca Pharma India Limited (NSE: ASTRAZEN)
India
· Delayed Price · Currency is INR 6,319.85
+14.40 (0.23%)
Nov 22, 2024, 3:29 PM IST
AstraZeneca Pharma India Revenue
AstraZeneca Pharma India had revenue of 4.16B INR in the quarter ending September 30, 2024, with 33.78% growth. This brings the company's revenue in the last twelve months to 14.85B, up 30.10% year-over-year. In the fiscal year ending March 31, 2024, AstraZeneca Pharma India had annual revenue of 12.96B with 29.17% growth.
Revenue (ttm)
14.85B
Revenue Growth
+30.10%
P/S Ratio
n/a
Revenue / Employee
18.56M
Employees
940
Market Cap
158.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 12.96B | 2.93B | 29.17% |
| Mar 31, 2023 | 10.03B | 1.97B | 24.50% |
| Mar 31, 2022 | 8.06B | -79.60M | -0.98% |
| Mar 31, 2021 | 8.14B | -182.50M | -2.19% |
| Mar 31, 2020 | 8.32B | 1.04B | 14.21% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAstraZeneca Pharma India News
- 6 weeks ago - AstraZeneca Pharma India shares surge over 8% amid focus on cancer projects and clinical trials - Business Upturn
- 7 weeks ago - AstraZeneca Pharma surges over 7%, hits 52-week high during early trades - Business Upturn
- 2 months ago - AstraZeneca gets nod to launch cancer drug - The Times of India